Abemaciclib-Faslodex Combo Increases Progression-free Survival in Advanced Breast Cancer
Author: Ines Martins / Source: Breast Cancer News Adding the CDK4/6 inhibitor...
WHAT'S UP IN
Hormone receptor
Ribociclib improves progression-free survival in advanced breast cancer
The addition of the CDK4/6 inhibitor ribociclib to letrozole therapy significantly improves...
ESMO 2016: Ribociclib Improves Progression-Free Survival in Advanced Breast Cancer
The addition of the CDK4/6 inhibitor ribociclib to letrozole therapy significantly improved...
